AU
EL icon

AlphaGrep UK’s Estee Lauder EL Stock Holding History

AlphaGrep UK’s Portfolio EL Stock Details EL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,538
Closed -$254K – 795
2026
Q1 		$254K Buy
+3,538
New +$362K 0.07% 590

Other funds holding EL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $15.2B AUM 1.56% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AlphaGrep UK's EL Position: Q2 2026 in Review

AlphaGrep UK sold out of Estee Lauder (EL) in Q2 2026, closing a stake of 3,538 shares — an estimated $254K sold.

AlphaGrep UK first reported a position in EL in Q1 2026 and held it in 1 quarter. The position peaked at $254K in Q1 2026. 771 funds tracked by Wall St. Rank hold EL as of Q2 2026.

  • AlphaGrep UK reported no remaining Estee Lauder position as of Q2 2026 after selling out during the quarter.
  • AlphaGrep UK sold 3,538 Estee Lauder shares in Q2 2026, an estimated $254K.
  • AlphaGrep UK first reported a position in Estee Lauder in Q1 2026 and held it in 1 quarter.
  • AlphaGrep UK's Estee Lauder position peaked at $254K in Q1 2026.
  • 771 funds tracked by Wall St. Rank held Estee Lauder as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.